éå»1ã¶æéã«Coya Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã7åã«åºã¥ãããŒã¿ã
仿ãCOYAã¯6ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããCOYAã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯15.167ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -0.283ã«ç¶ããCOYAã®FY2026Q3ã®EPSã¯-0.340ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.28 ã§ããããCoya Therapeutics IncCOYA ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.32 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.34 ãšäºæ³ãããŸãã